SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2627 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Akarna Therapeutics Ltd.. (2/16/16). "Press Release: Akarna Therapeutics Raises $15 Million Series B Financing to Develop Novel FXR Agonist-Based Therapies for the Treatment of NASH and other Fibrotic Diseases". San Diego, CA & Cambridge. 2016-02-16
Owlstone Inc.. (2/16/16). "Press Release: Owlstone Medical Wins NHS Contract for STRATA, Adapting Its Disease Breathalyzer technology for Precision Medicine and Companion diagnostics (CDx)". Cambridge. 2016-02-16
Consilium Strategic Communications Ltd.. (2/15/16). "Press Release: Consilium Strategic Communications Advises Shield Therapeutics plc on Its Successful £32.5m Fundraise and forthcoming IPO". London. 2016-02-15
Waters Corporation. (2/11/16). "Press Release: Waters and BioCity Debut New Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-02-11
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
Genomics England Ltd.. (2/11/16). "Press Release: Genomics England Enters Bioinformatics Partnership with Illumina". 2016-02-11
Mylan N.V.. (2/10/16). "Press Release: Mylan Full Year Adjusted Diluted EPS Up 21% to $4.30". Hertfordshire & Pittsburgh, PA. 2016-02-10
4D Pharma plc. (2/10/16). "Press Release: Acquisition [of Tucana Health Ltd.]". 2016-02-10
Adaptimmune Therapeutics plc. (2/9/16). "Press Release: U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma". Philadeliphia, PA & Oxford. 2016-02-09
Genomics England Ltd.. (2/9/16). "Press Release: Genomics England Selects Icon as Data Management Partner". 2016-02-09
Imperial Innovations Group plc. (2/4/16). "Press Release: Result of Placing [Not for United States, Australia, Canada or Japan or any other jurisdiction in which unlawful] ". 2016-02-04
Medicxi Ventures. (2/3/16). "Press Release: Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation". Castres. 2016-02-03
SBRI Healthcare. (2/3/16). "Press Release: £4.4 Million Awarded in Latest SBRI Healthcare Competition". 2016-02-03
EKF Diagnostics Holdings plc. (2/3/16). "Press Release: Trading Update". 2016-02-03
Adaptimmune Therapeutics plc. (2/3/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-02-03
AstraZeneca plc. (2/3/16). "Press Release: Tagrisso (osimertinib) Approved in EU as First-in-class Treatment for Patients with EGFR T790M Mutation-positive Metastatic Non-small Cell Lung Cancer". 2016-02-03
Adaptimmune Therapeutics plc. (2/2/16). "Press Release: Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration". London, Philadelphia, PA & Oxford. 2016-02-02
Cell and Gene Therapy Catapult, The. (2/2/16). "Press Release: Cell Therapy Catapult Is Now the Cell and Gene Therapy Catapult. New Name Reflects Mandate of the Catapult to Serve the Industry". London. 2016-02-02
Mission Therapeutics Ltd.. (2/2/16). "Press Release: Mission Therapeutics Raises £60 Million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform". Cambridge. 2016-02-02
Kymab Ltd.. (2/2/16). "Press Release: Kymab Succeeds in Revoking Regeneron’s UK VelocImmune Patents". Cambridge. 2016-02-02
Oxford Immunotec Global plc. (2/1/16). "Press Release: Patrick J. Balthrop, Sr., Former CEO of Luminex, Joins Oxford Immunotec Board of Directors". Oxford & Marlborough, MA. 2016-02-01
Francis Crick Institute Ltd., The. (2/1/16). "Press Release: HFEA Approval for New »Gene Editing« Techniques". 2016-02-01
Oxford BioMedica plc. (1/29/16). "Press Release: Oxford BioMedica Announces Initiation of Second CART Programme for Major Pharmaceutical Company". Oxford. 2016-01-29
Cancer Research UK. (1/27/16). "Press Release: CRT Announces License Agreement with MSD to Develop Inhibitors of PRMT5 for Cancer and Blood Disorders". 2016-01-27
Inivata Ltd.. (1/26/16). "Press Release: Inivata Completes £31.5 Million ($45M) Series A Fundraising Round". Cambridge. 2016-01-26
Immunocore Ltd.. (1/25/16). "Press Release: Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma". 2016-01-25
Apollo Therapeutics Fund. (1/25/16). "Press Release: Apollo Therapeutics. Consortium of World-Leading UK Universities and Global Pharmaceutical Companies Launch £40 Million Fund to Drive Therapeutic Innovation". London. 2016-01-25
Domainex Ltd.. (1/25/16). "Press Release: Domainex and Cresset Announce Drug Discovery Services Alliance". Cambridge. 2016-01-25
Abingworth LLP. (1/21/16). "Press Release: Abingworth Raises $105m for First Dedicated Clinical Co-Development Fund". 2016-01-21
Blue Scientific Ltd.. (1/15/16). "Press Release: Blue Scientific Now Exclusive Distributor for Ametek in Ireland". 2016-01-15
Microsaic Systems plc. (1/14/16). "Press Release: Grant of Share Options". 2016-01-14
Shire plc. (1/11/16). "Press Release: Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases". Dublin & Bannockburn, IL. 2016-01-11
Kymab Ltd.. (1/7/16). "Press Release: Kymab and MD Anderson Announce Strategic Partnership in Immuno-Oncology Research & Development". Cambridge & Houston, TX. 2016-01-07
Eurofins Scientific. (1/7/16). "Press Release: Eurofins Genomics and Weatherbys Ireland Join Forces to Genotype One Million Cattle". 2016-01-07
PsiOxus Therapeutics Ltd.. (1/7/16). "Press Release: PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board. Former President of GSK Oncology Adds Depth of Cancer R&D Leadership". Oxford. 2016-01-07
Illumina, Inc.. (1/7/16). "Press Release: Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT". San Diego, CA. 2016-01-07
Waters Corporation. (1/6/16). "Press Release: Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-01-06
Genomics plc. (1/4/16). "Press Release: Genomics and Vertex Collaborate to Identify Target Therapeutic Pathways". Oxford. 2016-01-04
Cellectis S.A.. (12/23/15). "Press Release: Cellectis Files First Clinical Trial Application for UCART19, an Allogeneic Gene Edited CAR T-Cell Product for Hematological Malignancies". New York. 2015-12-23
Bayer AG. (12/21/15). "Press Release: Bayer and CRISPR Therapeutics AG Join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases". Leverkusen & Basel. 2015-12-21
Microsaic Systems plc. (12/21/15). "Press Release: Directorate Changes". 2015-12-21
Oxford Immunotec Global plc. (12/18/15). "Press Release: Oxford Immunotec to Present at the 34th Annual J.P. Morgan Healthcare Conference". Oxford & Marlborough, MA. 2015-12-18
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Enhances Long-term Growth through Oncology Investment in Acerta Pharma". 2015-12-17
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Completes Acquisition of ZS Pharma". 2015-12-17
Ergomed plc. (12/16/15). "Press Release: Ergomed plc Provides Update on Co-Development Partnerships". Guildford. 2015-12-16
Malin Corporation plc. (12/16/15). "Press Release: Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.". Dublin. 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca to Strengthen Therapy Area Franchise through Acquisition of Takeda’s Respiratory Business". 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca Continues Strategic Investment in China to Accelerate Delivery of Innovative Biologics and Targeted Medicines". 2015-12-16
Genomics England Ltd.. (12/16/15). "Press Release: New NHS Centres Join 100,000 Genomes Project". 2015-12-16
AstraZeneca plc. (12/15/15). "Press Release: AstraZeneca Completes Agreement with Perrigo for Rights to Entocort in the US". 2015-12-15
Shire plc. (12/15/15). "Press Release: Shire to Present at 34th Annual J.P. Morgan Healthcare Conference". Lexington, MA. 2015-12-15
AstraZeneca plc. (12/14/15). "Press Release: Discussions with Acerta Pharma BV". 2015-12-14
Premaitha Health plc. (12/14/15). "Press Release: Premaitha Health Signs Investment Agreement with Thermo Fisher Scientific". Manchester. 2015-12-14
Blue Scientific Ltd.. (12/11/15). "Press Release: Parallel Imaging MS/MS Installed at Maastricht University M4I". 2015-12-11
Freeline Therapeutics Ltd.. (12/10/15). "Press Release: Syncona and UCLB Launch Freeline Therapeutics to Develop Gene Therapies for Bleeding Disorders". London. 2015-12-10
[iito] Business Intelligence. (12/9/15). "Press Release: Launches Today. New Business Web Portal for the UK and Irish Life Sciences Targets Decision Makers World-wide". Bremen & London. 2015-12-09
4D Pharma plc. (12/8/15). "Press Release: Placing to Raise £30 Million by the Issue of 3,797,469 New Ordinary Shares at 790p per Share". 2015-12-08
Key Organics Ltd.. (12/7/15). "Press Release: New Bionet 2nd Generation Premium Fragment Library". 2015-12-07
Bruker Corporation. (12/7/15). "Press Release: Bruker Introduces MetaboScape at MetaboMeeting 2015. Novel MetaboScape Software Links Experimental Data to Biology by Pathway Mapping". Cambridge. 2015-12-07
Cypralis Ltd.. (12/7/15). "Press Release: Cypralis Limited Announces Collaboration with Johnson & Johnson Innovation in the Field of Neurodegenerative Diseases". Ongar. 2015-12-07
Porvair plc. (12/7/15). "Press Release: Pre-close Trading Update and Acquisition". 2015-12-07
Auspherix Ltd.. (12/5/15). "Press Release: Auspherix Appoints Dr. Neil Miller as Chief Scientific Officer". Cambridge & Stevenage. 2015-12-05
Oxford Immunotec Global plc. (12/3/15). "Press Release: Oxford Immunotec Announces Availability of the T-SPOT.PRT Test in the United States". Oxford & Marlborough, MA. 2015-12-03
Microsaic Systems plc. (12/2/15). "Press Release: Trading Update and Directorate Changes". 2015-12-02
Kesios Therapeutics Ltd.. (12/2/15). "Press Release: Kesios Therapeutics Raises £19 Million in Series A Financing. Builds Management Team Led by Dr. Paolo Paoletti as CEO". London. 2015-12-02
Adaptimmune Therapeutics plc. (12/1/15). "Press Release: Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies". Philadeliphia, PA & Oxford. 2015-12-01
Protagen AG. (12/1/15). "Press Release: Protagen AG Joins MATURA Consortium to Support Identification of Treatment Response Predictors in Rheumatoid Arthritis (RA)". 2015-12-01
MedDay Pharmaceuticals S.A.S.. (12/1/15). "Press Release: MedDay Provides Update on MS-ON Study of MD-1003". Paris. 2015-12-01
Titian Software Ltd.. (12/1/15). "Press Release: Titian Focuses on Bringing Sample Management Solutions to Any Size of Organisation with New Appointments and Options". London. 2015-12-01
Qiagen N.V.. (12/1/15). "Press Release: Qiagen’s QuantiFERON-TB Test Chosen for Use in England Tender". Hilden. 2015-12-01
Heptares Therapeutics Ltd.. (11/30/15). "Press Release: Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas". London & Boston, MA. 2015-11-30
Heptares Therapeutics Ltd.. (11/25/15). "Press Release: Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-molecule CGRP Antagonists for Treatment of Migraine". Jerusalem & London. 2015-11-25
Biopta Ltd.. (11/25/15). "Press Release: ReproCell Acquires Biopta to Expand Its Drug Discovery Services". Glasgow. 2015-11-25
GlaxoSmithKline plc. (11/25/15). "Press Release: GSK Announces Start of Phase III Study of Sirukumab in Giant Cell Arteritis". London. 2015-11-25
Horizon Discovery Group plc. (11/25/15). "Press Release: Horizon Discovery Group plc Signs Three Diagnostic Agreements Worth an Initial $3.3 Million". Cambridge. 2015-11-25
ReproCell, Inc.. (11/24/15). "Press Release: Regarding the Synergy Effect of Making Biopta Limited a Wholly-owned Subsidiary". 2015-11-24
Adaptimmune Therapeutics plc. (11/24/15). "Press Release: Adaptimmune Initiates Phase I / II trial Evaluating its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients with the Most Common Type of Lung Cancer". Oxford & Philadelphia, PA. 2015-11-24
Horizon Discovery Group plc. (11/24/15). "Press Release: Horizon Discovery Group plc and Axol Bioscience Ltd Announce Strategic Partnership". Cambridge. 2015-11-24
Abzena plc. (11/24/15). "Press Release: Placing to Raise £20 Million and Acquisition [Not for United States, Australia, Canada, Japan, the Republic of Ireland, the Republic of South Africa, et al.] ". Cambridge. 2015-11-24
Abzena plc. (11/24/15). "Press Release: Half Year Results – Delivery, Acquisition and Growth". Cambridge. 2015-11-24
ERS Genomics Ltd.. (11/24/15). "Press Release: ERS Genomics Licenses Genome-editing Patents to Regeneron Pharmaceuticals". Dublin. 2015-11-24
Randox Laboratories Ltd.. (11/23/15). "Press Release: Randox Laboratories and Biosytems International Announce Completion of Clinical Trial and Licencing for QuantiPlasma Antibodies for Early Lung Cancer Diagnostics". 2015-11-23
Gurnet Point Capital. (11/19/15). "Press Release: Gurnet Point Capital Launches New Drug Development Company, Boston Pharmaceuticals, with $600 Million Commitment". Cambridge, MA. 2015-11-19
Boston Pharmaceuticals. (11/19/15). "Press Release: Boston Pharmaceuticals Appoints Santiago Arroyo, M.D., Ph.D., as Chief Medical Officer and Constantine Chinoporos, as Chief Business Officer". Cambridge, MA. 2015-11-19
Faron Pharmaceuticals Oy. (11/17/15). "Press Release: Admission to AIM and First Day of Dealings. £10 million Fundraise to Progress Phase III Clinical Trial [Not for US, AU, CA, JP, ZA, IE or any other jurisdiction where unlawful]". 2015-11-17
MGB Biopharma Ltd.. (11/17/15). "Press Release: MGB Biopharma Successfully Completes Feasibility Study with Topical Formulation of its Lead Antibacterial MGB-BP-3". Glasgow. 2015-11-17
Axol Bioscience Ltd.. (11/16/15). "Press Release: Axol Bioscience Appoints Chief Business Officer". 2015-11-16
Thermo Fisher Scientific Inc.. (11/13/15). "Press Release: Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes". Waltham, MA. 2015-11-13
Mylan N.V.. (11/13/15). "Press Release: Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer". Hertfordshire & Pittsburgh, PA. 2015-11-13
Adaptimmune Therapeutics plc. (11/13/15). "Press Release: Adaptimmune Reports First Quarter Financial Results for Fiscal Year 2015-16". Philadeliphia, PA & Oxford. 2015-11-13
Roche. (11/12/15). "Press Release: Roche to Restructure Its Manufacturing Network for Small Molecules". Basel. 2015-11-12
NightstaRx Ltd.. (11/12/15). "Press Release: NightstaRx Announces the Start of a Miami Gene Therapy Study to Treat Choroideremia". London. 2015-11-12
Genomics England Ltd.. (11/12/15). "Press Release: Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and Cancer". London, et al.. 2015-11-12
Adaptimmune Therapeutics plc. (11/12/15). "Press Release: Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference". Philadeliphia, PA & Oxford. 2015-11-12
Uniqure N.V.. (11/12/15). "Press Release: Uniqure to Present at the Jefferies 2015 Global Healthcare Conference – London". Amsterdam. 2015-11-12
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
Evotec AG. (11/11/15). "Press Release: Evotec to Present at Two Upcoming IR Conferences in November". Hamburg. 2015-11-11
Affimed N.V.. (11/11/15). "Press Release: Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference – London". Heidelberg. 2015-11-11
Novasep S.A.. (11/10/15). "Press Release: Novasep and CPI Advance Innovation in UK Biopharmaceutical Manufacturing". Pompey. 2015-11-10
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top